Is clinical tolerance possible after allergen immunotherapy?
Abstract
There is a growing evidence that allergen immunotherapy (AIT) can provide significant and long-lasting clinical benefit for a number of allergic individuals. However, it is less clear if AIT results in clinical tolerance, which is characterized by a persistent state of clinical non-reactivity to allergens after therapy is finished. Addressing this knowledge gap is particularly relevant for patients undergoing AIT for food allergies, as anything less than complete tolerance could have potentially devastating consequences. An increasing number of studies, in particular those involving oral immunotherapy, are attempting to assess tolerance induction following AIT. Clinical tolerance does appear to be achievable in a subset of patients undergoing AIT, but whether this is equivalent to the type of tolerance observed in nonallergic individuals remains unknown. Developing established criteria for assessing tolerance induction, as well as the use of consistent terminology when describing clinical tolerance, will be important for determining the disease-modifying potential of AIT.
Link To:
Moran TP1, Burks AW.
Is clinical tolerance possible after allergen immunotherapy?
Curr Allergy Asthma Rep. 2015 May;15(5):23. doi: 10.1007/s11882-015-0523-3.
http://www.ncbi.nlm.nih.gov/pubmed/26139331
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766811/